JCB logo
MBoC5 from Garland Science
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 31 October 2005. doi:10.1083/jcb1713rr4
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 171, Number 3, 407-407
This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Research Roundup

NO link to destruction

Two domains of cell behavior—protein modification by nitric oxide (NO) and ubiquitin-dependent protein destruction by the N-end rule pathway—have been united by Rong-Gui Hu, Jun Sheng, Alexander Varshavsky, and colleagues (Caltech, Pasadena, CA). They find that NO oxidizes NH2-terminal cysteines on certain proteins, thus marking them for future destruction. NO could therefore act as a very spatially and temporally delimited source of a destruction signal.

Cysteine was already known to be destabilizing when present as an NH2-terminal residue, and there were hints that its oxidation might be involved. The Caltech group now find that oxidation is essential to make the cysteine a substrate for arginyl transferase. The arginylated protein is then destroyed by the rest of the N-end rule pathway.

One substrate of this pathway is shown to be the GTPase-activating protein RGS4. It is no longer arginylated and is more abundant in vivo when either arginyl transferase is deleted or NO levels are reduced pharmacologically. Two other RGS proteins are also substrates, and ~30 uncharacterized proteins are candidates.

NO's short half-life, says Varshavsky, gives you the possibility of regulating proteins through on a subcellular level. NO-related drugs for regulating blood vessels and heart function may become more specific if they could be targeted to the N-end rule's part of NO signaling. {rr_end}

Reference:

Hu, R.-G., et al. 2005. Nature. doi:10.1038/nature04027.



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents